Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-011246
Filing Date
2025-02-11
Accepted
2025-02-11 09:18:26
Documents
1
Period of Report
2025-02-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm255946-8_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm255946-8_4seq1.xml 4 21460
  Complete submission text file 0001104659-25-011246.txt   23094
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5 RADNOR CORP CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address
Hulihan Joseph (Reporting) CIK: 0001794018 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36576 | Film No.: 25607895